Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 10 809,18 kr, with a 24-hour trading volume of 50,26B kr. The asset's market cap is 9,67T kr, after moving 3.38% in the last day.
Tokenized Eli Lilly And Co is trading at 10 870,33 kr, with a tokenized market cap of 57,97M kr and a 24-hour trading volume of 24,02M kr. The tokenized asset has moved 3.08% in the past 24 hours.